The present invention provides a bio-electrode composition including a silicone bonded to a sulfonamide salt, wherein the sulfonamide salt is shown by the following general formula (1): ##STR00001##
wherein R.sup.1 represents a linear, branched, or cyclic alkylene group having 1 to 20 carbon atoms optionally having an aromatic group, an ether group, or an ester group, or an arylene group having 6 to 10 carbon atoms; Rf represents a linear, branched, or cyclic alkyl group having 1 to 4 carbon atoms and containing at least one fluorine atom; M.sup.+ is an ion selected from a lithium ion, a sodium ion, a potassium ion, and a silver ion. This can form a living body contact layer for a bio-electrode that is excellent in electric conductivity and biocompatibility, light-weight, manufacturable at low cost, and free from large lowering of the electric conductivity even though it is wetted with water or dried.

The present invention is intended to provide a gel sheet having a formulation providing an adhesive force on the skin side suitable for the skin (i.e., a gel having a low adhesive force and being able to withstand a tip pressure of a terminal and the like), and concurrently having a sufficient adhesive force against an electrode element on the side opposite to the skin side. The present invention is a gel sheet having a laminated structure of a layer A and a layer B, characterized in that the storage elastic modulus of the layer A at 23° C. and 10 Hz is 12,000 to 40,000 Pa, and the storage elastic modulus of the layer B at 23° C. and 10 Hz is 2,000 to 10,000 Pa.

Technologies and implementations for a wearable medical device (WMD). The technologies and implementations facilitate improved comfort and usability of WMDs. Additionally, the technologies and implementations include WMDs having wearable cardioverter defibrillator capabilities.

Embodiments of devices and methods for evaluating tissue are disclosed. In one embodiment, a method for measuring a characteristic of a tissue may include passing a current through the tissue, measuring a signal corresponding to the voltage resulting from passing the current through the tissue, analyzing current passed through the tissue and resulting voltage to determine the electrical characteristics of the tissue; and analyzing the electrical characteristics of the tissue to determine a status of the tissue. Methods for achieving relatively constant sensor application pressure are disclosed.

Diagnostic apparatus includes a plurality of antennas, which are configured to be disposed at different, respective locations on a thorax of a living body so as to direct radio frequency (RF) electromagnetic waves from different, respective directions toward a heart in the body and to output RF signals responsively to the waves that are scattered from the heart. Processing circuitry is configured to process the RF signals over time so as to provide a multi-dimensional measurement of a movement of the heart.

The present disclosure relates generally to bioactive releasing membranes utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. More particularly, the disclosure relates to novel bioactive releasing membranes, to devices and implantable devices including these membranes, methods for forming the bioactive releasing membranes on or around the implantable devices, and to methods for monitoring analyte levels in a biological fluid sample using an implantable analyte detection device.

Diagnostic apparatus includes a plurality of antennas, which are configured to be disposed at different, respective locations on a thorax of a living body so as to direct radio frequency (RF) electromagnetic waves from different, respective directions toward a heart in the body and to output RF signals responsively to the waves that are scattered from the heart. Processing circuitry is configured to process the RF signals over time so as to provide a multi-dimensional measurement of a movement of the heart.

The present invention discloses a holder carrying thereon a sensor to measure a physiological signal of an analyte in a biological fluid, wherein the sensor has a signal detection end and a signal output end, and the holder includes an implantation hole being a channel for implanting the sensor and containing a part of the sensor, a fixing indentation containing the sensor, a filler disposed in the fixing indentation to retain the sensor in the holder, and a blocking element disposed between the implantation hole and the fixing indentation to hold the sensor in the holder and restrict the filler in the fixing indentation.

A medical patch configured for being applied to a patient and for communicating with an in-vivo device located within the patient’s body; The medical patch comprises an adhesive surface configured for adhering the patch to the patient’s skin; and a communication arrangement configured for providing communication between the medical patch and the in-vivo device.

A dry electrode and a wearable device are configured to improve the adhesiveness with a skin. The dry electrode includes: an electrode core; and an electrode pad that is conducted to the electrode core, in which the electrode core includes a plate portion that is surrounded by the electrode pad, and a core main body portion that protrudes from the plate portion, and is at least partially exposed to an outside of the electrode pad, and the electrode pad includes conductive rubber or a conductive elastomer having a volume resistivity of 0.5 to 10.0 Ω.Math.cm.